ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Support Contract Recompetition

July 6, 1990

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

DCPC Board Approves New Intramural Laboratory for Diet And Nutrition; NCAB to Consider It Next

May 22, 1987

Methylene Chloride Mortality Study Approved By DCE board

June 27, 1986

NIH Defends NCI Sponsored Travel

December 3, 2010